Results 221 to 230 of about 59,084 (264)
Some of the next articles are maybe not open access.
Hemostatic Agents and Their Safety
Journal of Cardiothoracic and Vascular Anesthesia, 1999The pharmacologic management of hemostasis in patients undergoing cardiopulmonary bypass may be accompanied by adverse responses. Evaluating the safety profile of hemostatic agents (eg, lysine analogs, aprotinin, protamine, or even donor blood) should be done objectively.
openaire +2 more sources
Hemostatic effects of ephedrine
Thrombosis Research, 1992The effects of ephedrine on coagulation and on fibrinolysis were studied in six healthy volunteers. Six volunteers, matched by age and sex, served as untreated controls. Ephedrine was found to significantly prolong mean bleeding time by 2 minutes. Ephedrine has been proposed to activate fibrinolysis, but we found no increased tPA activity. The platelet
P A, Flordal, J, Svensson
openaire +2 more sources
Hemostatic defects in pregnancy
American Journal of Obstetrics and Gynecology, 1956Abstract During the past decade there have been numerous reports concerning the role of alterations of the blood coagulation mechanism in the genesis of hemorrhage during pregnancy and the puerperium. 1–9 Most frequently hemorrhage due to blood coagulation defects has been reported in cases of severe abruptio placentae, amniotic fluid embolism, or ...
openaire +2 more sources
Oxidized cellulose-based hemostatic materials
Carbohydrate Polymers, 2020Jiwei Li, Shaojuan Chen, Jinmei He
exaly
Emerging hemostatic materials for non-compressible hemorrhage control
National Science Review, 2022Ruonan Dong, Baolin Guo, Guo Baolin
exaly